Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Attention Deficit Disorder”

331 trials

Showing 20 of 331 results

Early research (Phase 1)UnknownNCT02206516
What this trial is testing

Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).

Who this might be right for
Adult Attention Deficit Disorder
Tel-Aviv Sourasky Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01939353
What this trial is testing

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Adult ADHD
Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Not applicableUnknownNCT05582928
What this trial is testing

Effects of EEG- Microstate Neurofeedback on Attention and Impulsivity in Adult Attention-deficit/Hyperactivity Disorder (ADHD) and Neurotypical Controls

Who this might be right for
ADHDHealthy
Nader Perroud 60
Not applicableStudy completedNCT00550667
What this trial is testing

Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood

Who this might be right for
Attention Deficit Disorder With Hyperactivity
National Taiwan University Hospital 1,120
Not applicableStudy completedNCT01659164
What this trial is testing

Psychological Treatment for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
ADHD
Karolinska Institutet 18
Not applicableStudy completedNCT02249299
What this trial is testing

Experimental Medicine in ADHD - Cannabinoids

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
King's College London 30
Testing effectiveness (Phase 2)WithdrawnNCT00562055
What this trial is testing

Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.

Who this might be right for
Attention Deficit Hyperactivity Disorder
Pfizer
Not applicableStudy completedNCT06946433
What this trial is testing

TDCS in Adults With ASD and/or ADHD Without Intellectual Disability

Who this might be right for
Autism Spectrum DisorderAttention Deficit Disorder With Hyperactivity
Hospital Universitari Vall d'Hebron Research Institute 25
Testing effectiveness (Phase 2)Study completedNCT01174355
What this trial is testing

ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit and Hyperactivity Disorder
NeuroDerm Ltd. 40
Post-approval studies (Phase 4)Ended earlyNCT04507204
What this trial is testing

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Purdue Pharma LP 267
Not applicableStudy completedNCT01270555
What this trial is testing

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)Substance Use Disorder (SUD)
Massachusetts General Hospital 32
Post-approval studies (Phase 4)Study completedNCT00190775
What this trial is testing

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 502
Testing effectiveness (Phase 2)Study completedNCT01243242
What this trial is testing

Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
ADHD
Alcobra Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT01399827
What this trial is testing

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)Deficient Emotional Self-Regulation (DESR)
Massachusetts General Hospital 2
Not applicableStudy completedNCT02364817
What this trial is testing

ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse

Who this might be right for
AlcoholismAttention Deficit Disorder With Hyperactivity
University Hospital, Lille 113
Large-scale testing (Phase 3)Study completedNCT02555150
What this trial is testing

A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
Rhodes Pharmaceuticals, L.P. 40
Not applicableStudy completedNCT02217371
What this trial is testing

Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
University Hospital, Bordeaux 19
Testing effectiveness (Phase 2)Study completedNCT01074294
What this trial is testing

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 740
Large-scale testing (Phase 3)Study completedNCT02803229
What this trial is testing

Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder

Who this might be right for
Cannabis Use DisorderAttention-deficit/Hyperactivity Disorder
New York State Psychiatric Institute 33
Testing effectiveness (Phase 2)Study completedNCT02547428
What this trial is testing

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Otsuka Pharmaceutical Development & Commercialization, Inc. 85
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation